Platelet Rich Plasma (PRP) Injection for knee Osteoarthritis (OA)
– Platelet Rich Plasma therapy in knee Osteoarthritis
Autologous platelet Rich Plasma (PRP) injections have gained attention in the last 5 years as a prosperous treatment for various musculoskeletal disease such as Knee Osteoarthritis (OA) (1, 2).
PRP is defined as a sample of autologous blood with concentrations of platelets above physiological baseline obtained by a centrifugation process which separates the liquid and solid components of blood (3). In the last 5 years, PRP injections have been accepted as a safe and efficient method for musculoskeletal conditions specially because it has a potential to improve the soft tissue healing. PRP contains antibacterial protein and platelets which are able to produce the growth factors, Cytokine and Chemokines that can involve in the inflammation and healing process (4).
PRP in Knee Osteoarthritis (OA)
Osteoarthritis (OA) is known as one of the most common pathological painful conditions in the elderly which impairs quality of life (5). Socioeconomic evaluations show OA treatment cost is a burden for both governments and individuals (6). Pain relief and improvement of joint function is the final goal of OA knee treatment which leads to quality of life improvement (7). Complications and risks cannot be ignored with surgical treatment options such as knee replacement, as a result, conservative treatment including analgesics medication, physical therapy, unloading bracing, and intra-articular injections are preferred to delay knee replacement surgery (8).
PRP injection in OA treatment has been investigated recently in terms of safety and efficacy (5-11). All mentioned studies demonstrated that PRP is an efficient procedure in terms of pain reduction and joint function in self report and VAS Score evaluation. In 2013, a systematic review (12) reported that PRP is effective in compare to the placebo. Another systematic review (7) showed that PRP in compared with Hyaluronic Acid and saline have more benefit in pain relief and functional improvement in patients with symptomatic knee OA at 1-year post injection. In 2015, a meta-analysis (13) reviewing the efficacy of PRP injections in knee OA revealed that although PRP is an effective method in pain reduction and joint function in knee OA, more research is needed to be able to recommend RPR as a routine treatment in knee OA treatment (13).
PRP injection in knee OA is relatively new treatment option, and it is safe in compare to surgical intervention, however, research is needed on efficacy and improvement of quality of life improvement of this method specially in Australia. Australian Medical Research is currently conducting a research project to evaluate the efficacy of PRP injection in knee OA.
Dr Yalda Mojaver, and Mr Tuscan Harris.
Australian Medical Research.
1. Suja Mohammed, James Yu. Platelet-rich plasma injections: an emerging therapy for chronic discogenic low back pain. Journal of Spine Surgery. 2018;4(1).
2. Hartman PP. Molecular Mechanisms of Biological Aging in Intervertebral Discs. . J Orthop Res 2016;34.
3. Hall MP BP, Meislin RJ. Platelet-rich plasma: Current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17:602-8.
4. Galliera E CM, Ban G. Platelet rich plasma therapy: inflammatory molecules involved in tissue healing. J Biol Regul Homeost Agents 2012:35S-42S.
5. Abate M, Verna S, Schiavone C, Di Gregorio P, Salini V. Efficacy and safety profile of a compound composed of platelet-rich plasma and hyaluronic acid in the treatment for knee osteoarthritis (preliminary results). Eur. 2015;25(8):1321-6.
6. Rahimzadeh P, Imani F, Faiz SHR, Entezary SR, Zamanabadi MN, Alebouyeh MR. The effects of injecting intra-articular platelet-rich plasma or prolotherapy on pain score and function in knee osteoarthritis. Clin Interv Aging. 2018;13:73-9.
7. Dai WL, Zhou AG, Zhang H, Zhang J. Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials. Arthroscopy. 2017;33(3):659-70.e1.
8. Crawford DC ML, Block JE Conservative management of symptomatic knee osteoarthritis: a flawed strategy. Orthop Rev (Pavia). 2013;5(1):e2.
9. Bansal H, Comella K, Leon J, Verma P, Agrawal D, Koka P, et al. Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis. J. 2017;15(1):141.
10. Halpern B, Chaudhury S, Rodeo SA, Hayter C, Bogner E, Potter HG, et al. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis. Clin J Sport Med. 2013;23(3):238-9.
11. Kanchanatawan W, Arirachakaran A, Chaijenkij K, Prasathaporn N, Boonard M, Piyapittayanun P, et al. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc. 2016;24(5):1665-77.
12. Khoshbin A, Leroux T, Wasserstein D, Marks P, Theodoropoulos J, Ogilvie-Harris D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy. 2013;29(12):2037-48.
13. Laudy AB, Bakker EW, Rekers M, Moen MH. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. BJSM online. 2015;49(10):657-72.
14. Kohn MD SA, Fernando ND. . Classifications in Brief: Kellgren-Lawrence Classification of Osteoarthritis. . Clinical Orthopaedics and Related Research 2016;474(8):1886-93. doi:10.007/s11999-016-4732-4.